Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Elisabeth Enzenhofer"'
Autor:
Elisabeth Enzenhofer, Thomas Parzefall, Georg Haymerle, Sven Schneider, Lorenz Kadletz, Gregor Heiduschka, Johannes Pammer, Felicitas Oberndorfer, Fritz Wrba, Benjamin Loader, Matthäus Christoph Grasl, Christos Perisanidis, Boban M Erovic
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167665 (2016)
HPV positive patients suffering from head and neck cancer benefit from intensified radiotherapy when applied as a primary as well as an adjuvant treatment strategy. However, HPV negative patients treated with surgery and adjuvant radiotherapy lack va
Externí odkaz:
https://doaj.org/article/6fcac694a90a47849164f3a1fc9afd8f
Publikováno v:
Journal of Skin Cancer, Vol 2013 (2013)
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine tumor of the skin with a mortality rate of approximately 25% (Peloschek et al., 2010). Accurate assessment of nodal involvement in patients with MCC predicts significantly overall outco
Externí odkaz:
https://doaj.org/article/a6832d1ef19e4174ad9b479485ed974d
Autor:
Ulana Kotowski, Rudolf Seemann, Elisabeth Enzenhofer, Gregor Heiduschka, Dietmar Thurnher, Rainer Schmid, Isabella Stanisz, Lorenz Kadletz
Publikováno v:
Head & Neck. 39:900-907
Background Carcinogenesis is determined by various epigenetic events, such as histone deacetylation. The purpose of this study was to investigate the effect of the new histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma
Publikováno v:
Acta Oto-Laryngologica. 137:320-325
On the one hand, AZD5582, an inhibitor of inhibitor of apoptosis family proteins (IAP), leads to cellular growth arrest and induction of apoptosis in head and neck squamous cell carcinoma (HNSCC) cell lines. On the other hand, it is a viable candidat
Autor:
Sven Schneider, Lorenz Kadletz, Klaus Aumayr, Gregor Heiduschka, Claudia Lill, Elisabeth Enzenhofer
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 274:467-475
Salivary gland carcinomas are a rare malignancy. Therefore, little is known about biomarkers and cancer stem cells in salivary gland malignancies. Double cortin-like kinase 1 (DCLK1) is a promising therapeutic target and cancer stem cell marker, pred
Autor:
Gregor Heiduschka, Rainer Schmid, Lorenz Kadletz, Julian Domayer, Elisabeth Enzenhofer, Dietmar Thurnher
Publikováno v:
Oncology Letters. 10:1281-1286
Two-dimensional (2D) monolayer cell culture models are the most common method used to investigate tumor cells in vitro. In the few last decades, a multicellular spheroid model has gained attention due to its adjacency to tumors in vivo. The aim of th
Autor:
A Schratter-Sehn, Erich Vyskocil, Wolfgang Lechner, Edgar Selzer, Georg Haymerle, Boban M. Erovic, M Stock, B Bachtiary, Elisabeth Enzenhofer
Publikováno v:
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-LaryngologyCervico-Facial Surgery. 43(2)
Autor:
Ulana Kotowski, Lorenz Kadletz, Gregor Heiduschka, Isabella Stanisz, Dietmar Thurnher, Georg Haymerle, Markus Brunner, Elisabeth Enzenhofer
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 272:3451-3456
Since the prognosis of head and neck squamous cell carcinoma (HNSCC) still remains poor, identifying novel chemotherapeutic agents is of outmost importance. The anticancer potential of quinoxalines has been described in various tumor entities. Carove
Autor:
Georg Haymerle, Gregor Heiduschka, Benjamin Loader, Sven Schneider, Lorenz Kadletz, Thomas Parzefall, Johannes Pammer, Fritz Wrba, Matthäus Christoph Grasl, Elisabeth Enzenhofer, Christos Perisanidis, Felicitas Oberndorfer, Boban M. Erovic
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 12, p e0167665 (2016)
PLoS ONE, Vol 11, Iss 12, p e0167665 (2016)
Introduction HPV positive patients suffering from head and neck cancer benefit from intensified radiotherapy when applied as a primary as well as an adjuvant treatment strategy. However, HPV negative patients treated with surgery and adjuvant radioth
Autor:
Elisabeth, Enzenhofer, Lorenz, Kadletz, Isabella, Stanisz, Ulana, Kotowski, Rudolf, Seemann, Rainer, Schmid, Dietmar, Thurnher, Gregor, Heiduschka
Publikováno v:
Headneck. 39(5)
Carcinogenesis is determined by various epigenetic events, such as histone deacetylation. The purpose of this study was to investigate the effect of the new histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma (HNSCC) ce